Brain-disease trials help drug developer buck biotech sell-off
AUCKLAND: Orphan drug developer Neuren Pharmaceuticals is bucking the biotech sell-off. Its share price has…
AUCKLAND: Orphan drug developer Neuren Pharmaceuticals is bucking the biotech sell-off. Its share price has…